19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
Staffing Firm Used Unlawful Means to Screen Out Applicants With Disabilities, Federal Agency Charged...
Read More >
Governor Baker’s office issued a guidance letter on March 25, 2020 in an attempt to resolve confusi...
Read More >
Concerns about the price of oil have left the industry reluctant to strike deals, bringing down volu...
Read More >
2018 saw the enactment of important changes to CASPA, a Pennsylvania law that helps contractors and ...
Read More >
. . . if they do it right. (Part 3 of a four-part series.) The National Labor Relations Board rece...
Read More >
In MV Transportation, Inc., a 3 to 1 majority of the National Labor Relations Board recently abandon...
Read More >